Stage I Childhood Lymphoblastic Lymphoma [clinicaltrials_resource:0ddd5b6bf1483bad0f7e920259f04caf]
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant [clinicaltrials:NCT00078858]Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00089011]Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00105001]Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer [clinicaltrials:NCT00112593]A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies [clinicaltrials:NCT00343798]Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer [clinicaltrials:NCT01053494]Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant [clinicaltrials:NCT01231412]Sirolimus, Cyclosporine, and Mycophenolate Mofetil In Preventing Graft-Versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant [clinicaltrials:NCT01251575]Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas [clinicaltrials:NCT01793233]Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant [clinicaltrials:NCT01959477]
condition [clinicaltrials_vocabulary:condition]
Stage I Childhood Lymphoblastic Lymphoma [clinicaltrials_resource:0ddd5b6bf1483bad0f7e920259f04caf]
Bio2RDF identifier
0ddd5b6bf1483bad0f7e920259f04caf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0ddd5b6bf1483bad0f7e920259f04caf
identifier
clinicaltrials_resource:0ddd5b6bf1483bad0f7e920259f04caf
title
Stage I Childhood Lymphoblastic Lymphoma
@en
label
Stage I Childhood Lymphoblasti ...... d5b6bf1483bad0f7e920259f04caf]
@en